Devlin Jodi 4
4 · TriSalus Life Sciences, Inc. · Filed Aug 31, 2023
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Employee Stock Option (right to buy)
2023-08-30+195,000→ 195,000 totalExercise: $6.70Exp: 2033-08-29→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of August 28, 2023, and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the vesting commencement date.